Haematology

Simple saline spray is as effective as drug therapy for treating chronic nosebleeds

Squirting a simple saline solution into the nostrils twice a day could alleviate chronic nosebleeds just as effectively as administering any one of three different medication sprays, a study shows.  A total of 121 people were randomly assigned to receive bevacizumab, estriol, tranexamic a…

EMA recommends cell-based therapy to reduce complications from stem cell transplants

A genetically modified cell-based therapy that can reduce the risk of complications following a stem cell transplant in patients with certain blood cancers has been recommended for conditional marketing authority by the European Medicines Agency.…

FDA approves venetoclax for chronic lymphocytic leukaemia

The US Food and Drug Administration has approved venetoclax for the treatment of chronic lymphocytic leukaemia.…

Bridging anticoagulation: perioperative management of patients on anticoagulants

How patients on anticoagulants can be effectively managed in the perioperative period, including the evidence for the need for ‘bridging’ anticoagulation therapy and introduction of direct oral anticoagulants.…

Human coagulation factor X recommended for approval in Europe

The European Medicines Agency is recommending that human coagulation factor X (Coagadex) should be authorised to treat the rare bleeding disorder factor X deficiency.…

Funding partnership to benefit oncology and haematology pharmacy research

Pharmacy Research UK and the British Oncology Pharmacy Association have launched the BOPA-PRUK Research Awards with the aim of supporting pharmacists hoping to carry out research in the fields of oncology and haematology. …

High-dose flu vaccine with booster cuts flu rate in plasma cell disorder patients

Yale research shows high-dose vaccine Fluzone reduces rate of flu in PCD patients.…

Antidote to new oral anticoagulants proves effective

Anticoagulant effects of factor Xa inhibitors can be reversed by inactive recombinant factor Xa protein, andexanet, study shows.…

Low molecular weight heparins for treating venous thromboembolism

How to start patients on these common injected anticoagulants and optimise treatment.…

Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…